关于募集资金使用完毕并注销募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 证券代码：603309 证券简称：维力医疗 公告编号：2025-039 广州维力医疗器械股份有限公司 截至本公告披露日，公司2021年非公开发行股票募集资金已按规定全部使用完毕，全部募集资金专户均 已注销完毕。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准广州维力医疗器械股份有限公司非公开发行股票的批复》（证监 许可〔2021〕734号）核准，广州维力医疗器械股份有限公司（以下简称"公司"）以非公开发行股票方 式向特定投资者发行人民币普通股（A股）29,632,218股，发行价格为每股13.48元，募集资金总额为人 民币399,442,298.64元，募集资金净额为人民币392,814,940.16元。上述募集资金到位情况已经华兴会计 师事务所（特殊普通合伙）审验，并于2021年12月31日出具了《广州维力医疗器械股份有限公司验资报 告》（华兴验字[2021]21000110033号）。 截至本公告披露日，公司2021年非 ...

Core Viewpoint - The company intends to use its own funds to pay for investment projects and subsequently replace these expenditures with raised funds, ensuring efficient management and compliance with regulations [1][9]. Fundraising Overview - The company was approved to issue 20,000,000 shares, raising a total of RMB 231,420.00 million, with a net amount of RMB 214,574.66 million after deducting issuance costs [1]. - A subsequent issuance of 12,044,399 shares raised RMB 180,099.90 million, with a net amount of RMB 178,165.66 million after costs, all of which was received by October 23, 2023 [2]. Investment Project Details - The total investment for the initial public offering (IPO) projects is RMB 85,000.00 million, with the same amount planned to be funded from the raised capital [2]. - The company plans to utilize excess funds from the IPO for additional projects totaling RMB 136,317.22 million [3]. Reasons for Using Own Funds - The company cites regulatory requirements for salary payments and tax obligations as reasons for initially using its own funds for project expenses [5][6]. - To enhance operational efficiency and reduce procurement costs, the company prefers to make bulk purchases using its own funds [6]. - The need for flexibility in managing frequent and small expenses, as well as foreign currency payments, also supports the decision to use own funds initially [6]. Operational Process for Fund Replacement - The finance department will track expenditures made with own funds and will regularly transfer equivalent amounts from the raised funds account to the company's accounts [7]. - A detailed ledger will be maintained to document the transactions related to the replacement of funds [7]. Impact on Daily Operations - The approach of using own funds for project expenses is expected to improve the efficiency of fund usage and project implementation without affecting the normal operation of the investment projects [8]. Review and Approval Process - The board of directors and the supervisory board have approved the use of own funds for project expenses, confirming compliance with legal and regulatory requirements [8][9].

Core Viewpoint - The company has announced the use of its own funds to pay for investment projects and will subsequently replace these with raised funds, ensuring compliance with regulatory requirements and improving fund utilization efficiency [1][9][10]. Fundraising Overview - The company raised a total of RMB 2,314,200,000 from its initial public offering, with a net amount of RMB 2,145,746,574.65 after deducting issuance costs [1]. - In a subsequent issuance, the company raised RMB 1,781,656,587.99, with the funds fully received by October 23, 2023 [2]. Investment Project Details - The total investment for the initial public offering project was RMB 85,000,000, all of which has been completed [3]. - The company adjusted its fundraising project amounts, with a total of RMB 433,006.29 allocated for various projects, including RMB 375,953.25 for high-integration analog front-end and mixed-signal product development [4][6]. Reasons for Using Own Funds - The company intends to use its own funds for project payments to comply with banking regulations regarding salary payments and to enhance operational efficiency [6][7]. - Using own funds allows for bulk purchasing of materials and equipment, which is more cost-effective [7]. - The company aims to streamline the management of frequent and fragmented expenses related to project implementation [7]. Operational Process for Fund Replacement - The finance department will compile a detailed monthly report of expenditures paid with own funds, which will be reviewed and approved before transferring equivalent amounts from the fundraising account [8]. - A ledger will be maintained to track the replacement of own funds with raised funds, ensuring transparency and compliance with regulatory oversight [8]. Impact on Daily Operations - The decision to use own funds for project payments is expected to enhance the efficiency of fund utilization and project implementation without affecting the normal operation of the investment projects [9]. Review and Approval Process - The board of directors and the supervisory board have approved the use of own funds for project payments, confirming that the process adheres to legal and regulatory requirements [9][10].

Summary of Key Points Core Viewpoint - The company plans to temporarily use part of its idle raised funds, not exceeding RMB 60 million, to supplement its working capital, ensuring that this does not affect the normal implementation of its fundraising investment projects [6][7][8]. Group 1: Fundraising Overview - The company raised a total of RMB 754.38 million by issuing 51.67 million shares at RMB 14.60 per share, with actual funds received amounting to RMB 675.83 million after deducting issuance costs of RMB 78.55 million [1]. - The funds were deposited in a dedicated account for management [1]. Group 2: Investment Project Status - The company has approved the use of RMB 57 million of the raised funds to repay bank loans and has made adjustments to the implementation of certain investment projects without changing their overall direction or total investment amount [2][3]. - The company has also approved the use of remaining funds from the "Kunshan Hanjing Precision Connector Production Project" for new projects, including "Semiconductor Metal Heat Sink Material Project" and "Automotive High-Frequency Signal Cable and Connector Project" [3]. Group 3: Use of Idle Funds - The company intends to use idle funds temporarily to alleviate liquidity pressure, with an estimated savings of approximately RMB 1.8 million in financial costs based on a 3.0% annual loan interest rate [6]. - The use of these funds is limited to operations related to the company's main business and will not be used for high-risk investments or stock trading [6][7]. Group 4: Approval Process - The board of directors and the supervisory board have both approved the plan to use idle funds, confirming that it will not affect the normal operation of fundraising projects and will not harm shareholder interests [7][8].

Core Viewpoint - The report provides a verification of the use of previously raised funds by Suzhou Mawei Technology Co., Ltd., confirming that the funds have been utilized in accordance with regulatory requirements and that there are no significant misstatements in the financial reporting [1][2]. Summary by Sections Previous Fundraising Overview - The total amount raised from the issuance of shares was approximately RMB 608.50 million, with a net amount of RMB 604.69 million after deducting issuance costs [3]. - A second issuance raised approximately RMB 2.81 billion, with a net amount of RMB 2.79 billion after costs [4]. Fund Usage and Balance - As of December 31, 2024, the company has fully utilized the funds from the first issuance, totaling RMB 607.94 million [5]. - The remaining balance of unutilized funds as of December 31, 2024, is RMB 380.20 million, primarily held in structured deposits [5][6]. Fund Management - The company has established a fund management system in compliance with regulatory requirements to protect investor interests [5]. - A tripartite supervision agreement was signed with the sponsor and banks to ensure proper management of the raised funds [5]. Investment Project Performance - There have been no changes to the investment projects funded by the previous fundraising [6][7]. - The projects funded have not reported any inability to account for benefits separately, nor have they fallen below the promised return thresholds [7]. Idle Fund Management - The company has received approval to use idle funds for cash management, allowing for investment in low-risk financial products [8][9]. - As of December 31, 2024, the company has utilized idle funds for structured deposits, with a balance of RMB 380 million in such investments [9][10]. Comparison with Public Disclosures - The actual use of funds aligns with previously disclosed information in regular reports [10]. Other Matters - The company plans to use surplus funds from specific projects to supplement working capital for daily operations [10].

General Principles - The company establishes a fundraising management system to ensure the proper management and use of raised funds, maximizing investor interests [2][3] - The fundraising refers to funds raised through various securities offerings, excluding funds raised for employee stock ownership plans [2] Fundraising Storage - Funds must be stored in a special account approved by the board of directors, and cannot be used for non-fundraising purposes [4][8] - If the actual net amount raised exceeds the planned amount, the excess funds must also be stored in the special account [4] Fundraising Usage - The company must adhere to specific requirements when using raised funds, including clear application procedures and compliance with the planned usage stated in the securities issuance application [11][13] - Funds should primarily be used for main business operations and not for financial investments or providing funds to related parties [13][14] Changes in Fundraising Usage - Any changes in the use of raised funds must be approved by the board of directors and disclosed to shareholders [22][23] - The company must provide detailed reasons for any changes in fundraising project implementation and ensure that new projects align with the main business [24][25] Management and Supervision of Fundraising - The company must accurately disclose the actual usage of raised funds and conduct regular audits to ensure compliance [28][30] - Independent financial advisors must conduct semi-annual investigations of the management and usage of raised funds [31][32]

河南明泰铝业股份有限公司 募集资金管理办法 第一章 总 则 第一条 为了规范河南明泰铝业股份有限公司（以下简称"公司"）募集资 金的使用与管理，提高募集资金使用效益，保护投资者的合法权益，根据《中华 人民共和国公司法》《中华人民共和国证券法》《上市公司监管指引第 2 号—— 上市公司募集资金管理和使用的监管要求》《上海证券交易所上市公司自律监管 指引第 1 号——规范运作》等法律、法规、规范性文件及《河南明泰铝业股份有 限公司章程》（以下简称"公司章程"）的有关规定，特制定本办法。 第二条 本办法所称募集资金系指公司通过公开发行证券（包括首次公开发 行股票、配股、增发、发行可转换公司债券、发行分离交易的可转换公司债券等） 以及非公开发行证券向投资者募集的资金，但不包括公司实施股权激励计划募集 的资金。 第三条 募集资金到位后，公司应即时办理验资手续，由具有证券从业资格 的会计师事务所审验并出具验资报告。 第四条 公司对募集资金的管理遵循募集资金专户存储、规范使用、如实披 露、严格管理的原则。 第五条 公司的董事和高级管理人员应当勤勉尽责，督促公司规范使用募集 资金，自觉维护公司募集资金安全，不得参与、协助或纵 ...

Group 1 - The company Shenzhen Jingzhida Technology Co., Ltd. has established a special account for the management of raised funds and signed a tripartite supervision agreement to ensure the proper use of these funds [2][4][5] - The company was approved by the China Securities Regulatory Commission to publicly issue 23,502,939 shares at a price of RMB 46.77 per share, raising a total of RMB 1,099.23 million, with a net amount of RMB 986.56 million after deducting issuance costs [2][3] - The special account was opened at a branch of Bank of China in Nanjing, and the balance as of May 16, 2025, was RMB 0 million, indicating that funds are being managed according to regulations [4][5] Group 2 - The tripartite supervision agreement includes provisions for the management and use of raised funds, ensuring that funds are strictly used for designated projects and not for other purposes [5][7] - The agreement stipulates that the sponsor, CITIC Securities, will supervise the use of funds and conduct at least biannual on-site investigations [5][7][8] - The agreement will remain effective until all funds are fully utilized and the account is closed, ensuring accountability and compliance with regulations [8][9] Group 3 - A significant shareholder, Shenzhen Guozhong SME Development Private Equity Investment Fund, has reduced its shareholding from 5,230,902 shares to 4,700,558 shares, decreasing its ownership from 5.56% to 5.00% [12][13] - This reduction in shareholding is part of a previously disclosed plan and does not trigger a mandatory tender offer or change the company's controlling shareholder [12][14] - The company emphasizes that this change will not affect its governance structure or ongoing operations [15]

证券代码：603667 证券简称：五洲新春 公告编号：2025-042 浙江五洲新春集团股份有限公司关于部分募集资金专户完成销户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准浙江五洲新春集团股份有限公司非公开发行A股股票的批复》 （证监许可[2022]2136号）核准，公司于2023年7月非公开发行A股股票40,298,507股，发行价为每股人 民币13.40元，共计募集资金总额539,999,993.80元，扣除发行费用（不含增值税）人民币8,776,509.43元 后，本次发行募集资金净额为531,223,484.37元。上述款项已于2023年7月20日到公司募集资金专户，天 健会计师事务所（特殊普通合伙）对专户的募集资金到账情况进行了验资，并出具了"天健验（2023） 380号"《验资报告》。 公司已对募集资金进行专户存储管理，与存放募集资金的商业银行、保荐人签订了《募集资金专户存储 三方监管协议》（以下简称"《三方监管协议》"），并协同募投项目实施主体的 ...

Group 1 - The company, Anhui Hu塑股份有限公司, has completed the issuance of A-shares to specific investors, totaling 87,336,244 shares at a price of RMB 2.29 per share, raising approximately RMB 200 million before expenses [4] - After deducting issuance costs of RMB 3,075,032.46, the net amount raised is RMB 196,924,966.30, which has been deposited into a designated fund account [4] - The company has established a special account for the raised funds at Huishang Bank and signed a tripartite supervision agreement with the bank and the underwriter, Guotai Junan Securities [5][7] Group 2 - The special account is exclusively for the storage and use of funds raised from the issuance and has a current balance of RMB 198,939,998.76 as of May 22, 2025 [7] - The agreement stipulates that the underwriter will supervise the use of the funds and can conduct on-site investigations and inquiries [8] - The agreement will remain effective until all funds are fully utilized and the account is closed [9]